As Head of Banking Solutions, Giovanni works with global financial institutions to define strategic requirements and accelerate the adoption of advanced analytical capabilities for personalized pricing and decisioning using the Earnix platform. Previously Giovanni headed the Professional Services Banking Team in Earnix, a global team of consultants responsible for the design, management, and delivery of implementation projects for different LOBs: from unsecured lending to mortgages, from auto lending to short- and medium/long-term lending facilities to businesses. Over the last decade Giovanni has designed and delivered projects that every month impact over €10bn in new lending contracts globally. Giovanni has also led strategic consulting projects with focus on advanced analytics and on change management processes and operations.
Archives: Speakers
Saurav Gupta
Saurav joined InterSystems in 2006 and has been working in pre-sales and solutions architect roles with experience in technology and solution sales, enterprise application integration, data warehousing, business intelligence and software development. His key responsibilities include recommending technical architecture, solution design, migration, upgrade strategies, and operational best practices to InterSystems customers.
Prior to joining InterSystems, Saurav previously worked at NCR Corporation where he was responsible for establishing an off-shore enterprise data warehouse team in India, as well as Sopra Steria in software development.
Rick Baransky
Rick has 23 years of clinical research experience at multiple Clinical Research Organizations (CROs) in various roles, most recently including Sr. Director of Project Delivery, Sr. Director of Site Operations, Head of Just In Time Oncology Business Unit, Sr. Director – Site Collaborations, and Sr. Director of Clinical Management. Rick has 15+ years of Project and Clinical Management oversight, both as Director of Functional Team Leads and Line Management of CRAs. Additionally, Rick has 4+ years of Site Operations/Collaborations experience specializing in Oncology and Pediatrics.
Rick’s vast experience spans all areas of drug development, specializing in CRO delivery and oversight. Rick has global experience in both Project and Clinical Management oversight as well as Site Operations, spanning Phase I First in Human Trials through Phase IV. Rick has experience in multiple therapeutic areas, but has significant expertise in Cardiology, Vaccines, Hematology/Oncology, Pediatrics and Rare Diseases. Rick has a Bachelor’s of Science in Economics from Oswego State University and is currently located in Raleigh, North Carolina.
Rowan Milne
Mark Turner
Mark is a managing director in the London office where he leads the Regulatory Consulting team within Kroll’s Financial Services Compliance and Regulation practice. He specializes in advising the financial services industry on governance, risk management, systems and controls, and regulatory compliance matters.
Prior to Kroll, Mark’s experience includes audit, banking, owning/managing a retail business, regulation and management consultancy. He was a senior risk consultant within the Risk Specialist Division at the Prudential Regulation Authority (PRA), and prior to that the Financial Services Authority (FSA). In recent years, Mark has become one of the industry’s leading experts on individual accountability, and has advised some of the world’s largest financial institutions on the UK’s Senior Managers and Certification Regime (SM&CR). Mark regularly advises Boards and Board Directors on Governance, Risk and Compliance matters, in both contentious and non-contentious situations. He has acted as Skilled Person under s166 (FSMA) on over 30 engagements spanning Governance, Risk, Controls, Client Assets (CASS), Financial Crime and Conduct of Business.
Mark is a Chartered Accountant with over 20 years’ experience within financial services. He holds a BSc in Mathematics from Imperial College, London.
Tommaso Migliore
Jo Cook
Nasser Belhabala
Catherine Tyner
Catherine Tyner brings 27 years of clinical research experience with a focus on Oversight Group Management for Clinical Endpoint Committees, Data Monitoring Committees, and other operations. Throughout her career, Ms. Tyner has led and developed oversight departments at Quintiles (now IQVIA), Novella Clinical, and Covance (now Fortrea), providing strategic management for over 500 clinical trials, including complex megatrials across diverse therapeutic areas. A recognized thought leader in endpoint adjudication best practices, Ms. Tyner has authored the industry’s seminal guidance on adjudication operations and best practice. In her new role at AG Mednet, Ms. Tyner will work to expand and tailor the value jointly created with new and existing CROs Trial Sponsors, Core Labs, and Academic Research Organizations, working closely to optimize the future of clinical process efficiency.
Anas Qawasmeh
Anas Qawasmeh heads the FinTech & Innovation Business Development team at DIFC Authority, which manages a portfolio of over 1,250 technology companies that leverage DIFC as a strategic hub for their growth, and expansion across the UAE and the region.
With a strong track record in financial technology and innovation, Anas brings a wealth of experience from global industry leading companies. Before joining DIFC, he spearheaded Business Development for FinTech and Ventures at Visa Inc. across the Levant within the Central Europe, Middle East and Africa region.
Prior to Visa, Anas was part of the Strategy Team at ByteDance, the parent company of TikTok. He played a critical role in shaping and leading the finance monetisation strategy during TikTok’s rapid expansion across the Middle East, Turkey, South Africa and Pakistan, contributing to the platform’s regional success and growth.